BRIEF published on 12/16/2025 at 09:58, 7 months 10 days ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 7 months 10 days ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
PRESS RELEASE published on 12/16/2025 at 09:53, 7 months 10 days ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
BRIEF published on 11/07/2025 at 15:44, 8 months 19 days ago Virbac: Update on shares and voting rights Euronext Paris Voting Rights Actions Transparency VIRBAC
BRIEF published on 09/12/2025 at 17:50, 10 months 14 days ago Virbac Reports Solid Growth in 2025 First Half Results Revenue Growth Operating Income VIRBAC 2025 Forecast Global Market Performance
PRESS RELEASE published on 09/12/2025 at 17:45, 10 months 14 days ago Virbac: 2025 Half-year results Virbac reports solid revenue growth of 5.6% in the first half of 2025, meeting adjusted operating income expectations. Targets for 2025 confirmed with revenue growth of 4-6% expected Financial Results Revenue Growth Operating Income VIRBAC Targets Confirmed
BRIEF published on 08/18/2025 at 09:35, 11 months 8 days ago Virbac reveals the remuneration of its new CEO General Manager Remuneration VIRBAC Free Shares Paul Martingell
PRESS RELEASE published on 08/18/2025 at 09:30, 11 months 8 days ago Virbac:: Paul Martingell's compensation terms Virbac's board of directors approves compensation terms for Paul Martingell as CEO, including fixed and variable components, long-term incentives, and exceptional benefits Board Of Directors CEO VIRBAC Paul Martingell Compensation Terms
BRIEF published on 07/04/2025 at 12:09, 1 year ago Virbac: Status of Shares and Voting Rights as of June 30, 2025 Euronext Paris Voting Rights Actions 2025 VIRBAC
PRESS RELEASE published on 07/04/2025 at 12:04, 1 year ago Virbac : Declaration of the number of shares and voting rights 06/2025 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris. Total voting rights: 12,706,453. Net total voting rights: 12,693,617 Euronext Paris Voting Rights Shares Financial Market Authority VIRBAC
Published on 07/25/2026 at 00:35, 1 day 21 hours ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 1 day 22 hours ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 23 hours ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 23 hours ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 2 days 1 hour ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/26/2026 at 19:12, 2 hours 33 minutes ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/26/2026 at 18:46, 2 hours 59 minutes ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/24/2026 at 18:44, 2 days 3 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:50, 2 days 2 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 08:00, 2 days 13 hours ago Accor signs a definitive binding agreement on the sale of its stake in Essendi
